InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Protalix BioTherapeutics, Inc.

PLX Clue Score38
United States Fiscal year ends December CIK 0001006281 Results filed 12 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Dror Bashan
19 Dec 2025
President and CEO
Buy
56,000
$1.81
$101.36K
Amos Bar-Shalev
18 Nov 2025
Director
Sell
168
$1.87
$314.16
Aharon Schwartz
10 Jun 2025
Director
Buy
129,000
$1.60
$205.88K
Dror Bashan
19 Oct 2023
President and CEO
Buy
16,129
$1.41
$22.74K
Dror Bashan
19 Oct 2023
President and CEO
Buy
48,387
$1.40
$67.74K
Aharon Schwartz
3 Jan 2023
Director
Buy
110,000
$1.42
$155.82K
Dror Bashan
11 Apr 2022
President and CEO
Buy
68,000
$1.50
$102.00K
Dexcel Pharma Technologies Ltd.
3 Jun 2021
10% owner
Sell
857,506
$2.25
$1.93M
Dexcel Pharma Technologies Ltd.
2 Jun 2021
10% owner
Sell
61,211
$2.56
$156.55K
Aharon Schwartz
7 Apr 2020
Director
Buy
64,000
$2.43
$155.26K
Moshe Manor
16 May 2017
President & CEO
Buy
50,000
$0.81
$40.50K
Camber Capital Management LLC
2 Dec 2016
10% owner
Sell indirect
2,500,000
$0.32
$792.00K

What was left out

Form 4 filings counted 72
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 3,313,387
Sales filed before the plan box existed 3
History held since 5 Jan 2007